Caring for Children on COG AML protocols: Quick Hits and Nursing Tips (C205)

3:30 – 4:30 pm Thursday, October 28

coglogoAcute myeloid leukemia (AML) is the second most common form of leukemia in children, and the intensive therapy used to treat pediatric AML requires expert nursing knowledge.

The rate of event-free survival for childhood AML is estimated to be 55%, and intensification of current chemotherapy protocols is not possible because of the treatment’s known toxicity profile, which includes cardiotoxicity and infectious toxicity. The Children’s Oncology Group (COG) is working to improve the survival of pediatric AML patients through advances in risk stratification and new chemotherapy formulations, targeted therapies, and supportive care strategies. In this session, we will review the current COG protocols for children with newly diagnosed AML, AAML1831 (de novo AML), and AAML1531 (Down syndrome AML), through a nursing perspective, with a focus on targeted and investigational agents, supportive care measures, and patient and family education.

Speaker(s):
Stephanie Cox, MN NP
CNE Hours:
1
RX Hours:
0.25